Tag Archives: cancer

UK rolls out AI-based cancer detection for NHS patients

Leader in AI-powered cancer diagnostics, Ibex Medical Analytics and provider of digital pathology services in the NHS, LDPath, have announced the UK’s first rollout of clinical grade AI application for cancer detection in pathology. This platform will support pathologists in enhancing diagnostic accuracy and efficiency. WHY IT MATTERS Over the years, a global increase in cancer cases… Read More »

Cancer in the Age of COVID: Delayed Care May Reverse Survival Gains Particular Among Black People

There was great news published last week in An Update on Cancer Deaths in the United States from the Centers for Disease Control (CDC): cancer mortality rates have declined by 26% over 20 years, between 1999 to 2018. The drop in deaths from cancer in America was indeed positive during the current public health COVID-19… Read More »

Sugars could be the key to an earlier, more accurate test for prostate cancer

A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy is being developed by researchers at the University of Birmingham. The test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo distinct but… Read More »

Bristol Myers Squibb’s Opdivo, Yervoy score another lung cancer OK, this time alongside chemo

Bristol Myers Squibb’s Opdivo and Yervoy only just won their first approval in previously untreated metastatic non-small cell lung cancer, but the pair is already making it two. The FDA on Tuesday green-lighted the immuno-oncology duo alongside two cycles of platinum chemo for first-line patients without EGFR or ALK mutations, regardless of whether their tumors… Read More »

FDA Approves Braftovi (encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

Print this page April 8, 2020 – Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Braftovi® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) for the treatment of adult patients with metastatic colorectal cancer (CRC) with a BRAFV600E mutation, as detected by an FDA-approved test, after prior… Read More »